Lynne Bui
Director/Board Member at THARIMMUNE, INC.
Net worth: - $ as of 2024-04-29
Lynne Bui active positions
| Companies | Position | Start | End |
|---|---|---|---|
| THARIMMUNE, INC. | Director/Board Member | 2021-06-30 | - |
| Independent Dir/Board Member | 2021-06-30 | - | |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Chief Executive Officer | 2017-05-31 | - |
| Founder | - | - | |
| President | 2017-05-31 | - | |
| Global Cancer Research Institute | Chairman | - | - |
| Founder | - | - | |
| GCRI Foundation, Inc. | Chairman | - | - |
| Founder | - | - |
Career history of Lynne Bui
Former positions of Lynne Bui
| Companies | Position | Start | End |
|---|---|---|---|
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Chief Tech/Sci/R&D Officer | - | - |
Intellikine LLC
 Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | - | - |
| EXELIXIS, INC. | Chief Tech/Sci/R&D Officer | - | - |
Training of Lynne Bui
| University of California, Berkeley | Undergraduate Degree |
| David Geffen School of Medicine | Graduate Degree |
Statistics
International
| United States | 10 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
| Chairman | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| THARIMMUNE, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Intellikine LLC develops and manufactures small molecule drugs for the treatment of cancer. The company focused on the development of potent, selective small molecule inhibitors of the PI3K/Akt/mTOR pathway for the treatment of cancer, inflammation and autoimmune disorders. Intellikine was founded on May 2nd, 2007 and is headquartered in La Jolla, CA. | Health Technology |
Khloris Biosciences, Inc.
Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA. | Commercial Services |
| Global Cancer Research Institute | |
| GCRI Foundation, Inc. |
- Stock Market
- Insiders
- Lynne Bui
- Experience
